SGLT2 inhibitors exert their anti-inflammatory effects by inhibiting activation of the NLRP3 inflammasome. Secondary analyses of RCTs show that SGLT2is can reduce the risk of incident #gout @RheumNow #ACR25 https://t.co/IWgyDYEQoZ